Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: Role of Bumetanide in Treatment of Autism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating bumetanide for autism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Autism | Phase 3 | Status: RECRUITING